AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-88
Results: 1-25/88
HIGH-RATE OF CHROMOSOME-ABNORMALITIES DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION USING BCR AND ABL PROBES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: RIEDER H BONWETSCH C JANSSEN LAJ MAURER J JANSSEN JWG SCHWARTZ S LUDWIG WD GASSMANN W BARTRAM CR THIEL E LOFFLER H GOKBUGET N HOELZER D FONATSCH C
Citation: H. Rieder et al., HIGH-RATE OF CHROMOSOME-ABNORMALITIES DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION USING BCR AND ABL PROBES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 12(9), 1998, pp. 1473-1481
MUTATIONAL ANALYSIS OF THE TUMOR-SUPPRESSOR SMAD2 IN ACUTE LYMPHOID AND MYELOID-LEUKEMIA
Authors: WIESER R GRUBER B RIEDER H FONATSCH C
Citation: R. Wieser et al., MUTATIONAL ANALYSIS OF THE TUMOR-SUPPRESSOR SMAD2 IN ACUTE LYMPHOID AND MYELOID-LEUKEMIA, Leukemia, 12(7), 1998, pp. 1114-1118
THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA
Authors: FREUND M HEIL G ARNOLD R BALLEISEN L BUCHNER T DIEDRICH H EIMERMACHER H FONATSCH C GANSER A GASSMANN W HARTMANN F HIDDEMANN W KASPER C KNAUF WU KOCH P KUBICA U LINK H LOFFLER H LUDWIG WD MASCHMEYER G POMPE K SCHADECK C SCHMITZ N SCHONROCKNABULSI P SCHWONZEN M THIEL E WEISS A HOELZER D
Citation: M. Freund et al., THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA, Bone marrow transplantation, 22, 1998, pp. 10-10
LEUKEMIA-FREE SURVIVAL AND MORTALITY IN PATIENTS WITH REFRACTORY OR RELAPSED ACUTE-LEUKEMIA GIVEN MARROW TRANSPLANTS FROM SIBLING AND UNRELATED DONORS
Authors: GREINIX HT REITER E KEIL F FISCHER G LECHNER K DIECKMANN K LEITNER G SCHULENBURG A HOECKER P HAAS OA KNOEBL P MANNHALTER C FONATSCH C HINTERBERGER W KALHS P
Citation: Ht. Greinix et al., LEUKEMIA-FREE SURVIVAL AND MORTALITY IN PATIENTS WITH REFRACTORY OR RELAPSED ACUTE-LEUKEMIA GIVEN MARROW TRANSPLANTS FROM SIBLING AND UNRELATED DONORS, Bone marrow transplantation, 21(7), 1998, pp. 673-678
ALVEOLAR RHABDOMYOSARCOMA IN A 68-YEAR-OLD PATIENT IDENTIFIED BY CYTOGENETIC ANALYSIS BONE-MARROW
Authors: STINDL R FIEGL M REGELE H GISSLINGER H BREITENSEHER MJ FONATSCH C
Citation: R. Stindl et al., ALVEOLAR RHABDOMYOSARCOMA IN A 68-YEAR-OLD PATIENT IDENTIFIED BY CYTOGENETIC ANALYSIS BONE-MARROW, Cancer genetics and cytogenetics, 107(1), 1998, pp. 43-47
FLUORESCENCE IN-SITU HYBRIDIZATION CHARACTERIZATION OF THE CHROMOSOMAL BREAKPOINTS IN A CASE WITH INS(17-3) (Q11.2-Q21Q26.3) AND ACUTE MONOCYTIC LEUKEMIA
Authors: SCHNITTGER S JOACHIMMAYER E SCHOCH C FUCHS R FONATSCH C
Citation: S. Schnittger et al., FLUORESCENCE IN-SITU HYBRIDIZATION CHARACTERIZATION OF THE CHROMOSOMAL BREAKPOINTS IN A CASE WITH INS(17-3) (Q11.2-Q21Q26.3) AND ACUTE MONOCYTIC LEUKEMIA, Cancer genetics and cytogenetics, 106(2), 1998, pp. 122-127
AUSCHWITZ, NAZI MEDICINE AND THEIR VICTIMS - COMMENT OF 3 HUMAN GENETICISTS ON THE BOOK BY KLEE,ERNST
Authors: FONATSCH C MAROSI C REHDER H
Citation: C. Fonatsch et al., AUSCHWITZ, NAZI MEDICINE AND THEIR VICTIMS - COMMENT OF 3 HUMAN GENETICISTS ON THE BOOK BY KLEE,ERNST, Wiener Klinische Wochenschrift, 110(13-14), 1998, pp. 507-508
CORRELATION OF CYTOGENETIC, MOLECULAR CYTOGENETIC, AND CLINICAL FINDINGS IN 59 PATIENTS WITH ANLL OR MDS AND ABNORMALITIES OF THE SHORT ARMOF CHROMOSOME-12
Authors: STREUBEL B SAUERLAND C HEIL G FREUND M BARTELS H LENGFELDER E WANDT H LUDWIG WD NOWOTNY H BALDUS M GROTHAUSPINKE B BUCHNER T FONATSCH C
Citation: B. Streubel et al., CORRELATION OF CYTOGENETIC, MOLECULAR CYTOGENETIC, AND CLINICAL FINDINGS IN 59 PATIENTS WITH ANLL OR MDS AND ABNORMALITIES OF THE SHORT ARMOF CHROMOSOME-12, British Journal of Haematology, 100(3), 1998, pp. 521-533
IMMUNOPHENOTYPIC AND GENOTYPIC FEATURES, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME OF ADULT PRO-B ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF THE GERMAN MULTICENTER TRIALS GMALL 03 87 AND 04/89/
Authors: LUDWIG WD RIEDER H BARTRAM CR HEINZE B SCHWARTZ S GASSMANN W LOFFLER H HOSSFELD D HEIL G HANDT S HEYLL A DIEDRICH H FISCHER K WEISS A VOLKERS B AYDEMIR U FONATSCH C GOKBUGET N THIEL E HOELZER D
Citation: Wd. Ludwig et al., IMMUNOPHENOTYPIC AND GENOTYPIC FEATURES, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME OF ADULT PRO-B ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF THE GERMAN MULTICENTER TRIALS GMALL 03 87 AND 04/89/, Blood, 92(6), 1998, pp. 1898-1909
MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DISTINCT SUBSETS OFACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS ARE ASSOCIATED WITH A POOR-PROGNOSIS
Authors: DREYLING MH SCHRADER K FONATSCH C SCHLEGELBERGER B HAASE D SCHOCH C LUDWIG WD LOFFLER H BUCHNER T WORMANN B HIDDEMANN W BOHLANDER SK
Citation: Mh. Dreyling et al., MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DISTINCT SUBSETS OFACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS ARE ASSOCIATED WITH A POOR-PROGNOSIS, Blood, 91(12), 1998, pp. 4662-4667
A CASE OF ATYPICAL MYELODYSPLASTIC SYNDROME WITH MICROMEGAKARYOCYTES,NORMAL PLATELET COUNT, AND T(3-12)(Q21-P13) WITH INV(3)(Q21Q26)
Authors: SCHNITTGER S SCHOCH C STREUBEL B HINRICHS HF OTREMBA B PARWARESCH R FONATSCH C
Citation: S. Schnittger et al., A CASE OF ATYPICAL MYELODYSPLASTIC SYNDROME WITH MICROMEGAKARYOCYTES,NORMAL PLATELET COUNT, AND T(3-12)(Q21-P13) WITH INV(3)(Q21Q26), Genes, chromosomes & cancer, 20(3), 1997, pp. 292-298
HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF ACUTE LEUKEMIAS THE DEVELOPMENT OF BIOLOGICALLY DEFINED CONCEPTS
Authors: HIDDEMANN W JAHNSSTREUBEL G HAASE D SCHOCH C FONATSCH C WORMANN B BUCHNER T
Citation: W. Hiddemann et al., HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF ACUTE LEUKEMIAS THE DEVELOPMENT OF BIOLOGICALLY DEFINED CONCEPTS, European journal of cancer, 33, 1997, pp. 11-11
CHARACTERIZATION, MAPPING AND PARTIAL CDNA SEQUENCE OF THE 57-KD INTRACELLULAR KI-1 ANTIGEN
Authors: KOBARG J SCHNITTGER S FONATSCH C LEMKE H BOWEN MA BUCK F HANSEN HP
Citation: J. Kobarg et al., CHARACTERIZATION, MAPPING AND PARTIAL CDNA SEQUENCE OF THE 57-KD INTRACELLULAR KI-1 ANTIGEN, Experimental and clinical immunogenetics, 14(4), 1997, pp. 273-280
ACTIVATION OF A NOVEL GENE IN 3Q21 AND IDENTIFICATION OF INTERGENIC FUSION TRANSCRIPTS WITH ECOTROPIC VIRAL INSERTION SITE-I IN LEUKEMIA
Authors: PEKARSKY Y RYNDITCH A WIESER R FONATSCH C GARDINER K
Citation: Y. Pekarsky et al., ACTIVATION OF A NOVEL GENE IN 3Q21 AND IDENTIFICATION OF INTERGENIC FUSION TRANSCRIPTS WITH ECOTROPIC VIRAL INSERTION SITE-I IN LEUKEMIA, Cancer research, 57(18), 1997, pp. 3914-3919
NONLYMPHOCYTIC LEUKEMIA FOLLOWING CHEMOTHERAPY OF A GERM-CELL TUMOR
Authors: SESSLER R RUTHER U BOKEMEYER C RASSWEILER J SCHOCH C FALK S FONATSCH C
Citation: R. Sessler et al., NONLYMPHOCYTIC LEUKEMIA FOLLOWING CHEMOTHERAPY OF A GERM-CELL TUMOR, British Journal of Urology, 79(1), 1997, pp. 140-141
THE SIGNIFICANCE OF TRISOMY-8 IN DE-NOVO ACUTE MYELOID-LEUKEMIA - THEACCOMPANYING CHROMOSOME-ABERRATIONS DETERMINE THE PROGNOSIS
Authors: SCHOCH C HAASE D FONATSCH C HAFERLACH T LOFFLER H SCHLEGELBERGER B HOSSFELD DK BECHER R SAUERLAND MC HEINECKE A WORMANN B BUCHNER T HIDDEMANN W
Citation: C. Schoch et al., THE SIGNIFICANCE OF TRISOMY-8 IN DE-NOVO ACUTE MYELOID-LEUKEMIA - THEACCOMPANYING CHROMOSOME-ABERRATIONS DETERMINE THE PROGNOSIS, British Journal of Haematology, 99(3), 1997, pp. 605-611
MORPHOLOGICAL AND CYTOCHEMICAL FINDINGS IN 150 CASES OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
Authors: GASSMANN W LOFFLER H THIEL E LUDWIG WD SCHWARTZ S HAFERLACH T MAURER J RIEDER H FONATSCH C GOKBUGET N HOELZER D
Citation: W. Gassmann et al., MORPHOLOGICAL AND CYTOCHEMICAL FINDINGS IN 150 CASES OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS, British Journal of Haematology, 97(2), 1997, pp. 372-382
ALLELIC LOSS OF CHROMOSOMAL REGIONS IN 6P, 9Q AND 17P IN THE HODGKIN-REED-STERNBERG CELL-DERIVED CELL-LINE L1236
Authors: JOX A ZANDER T KORNACKER M FONATSCH C DIEHL V WOLF J
Citation: A. Jox et al., ALLELIC LOSS OF CHROMOSOMAL REGIONS IN 6P, 9Q AND 17P IN THE HODGKIN-REED-STERNBERG CELL-DERIVED CELL-LINE L1236, Blood, 90(10), 1997, pp. 3907-3907
COMPLEX CHROMOSOME-ABERRATIONS IN PATIENTS WITH DE-NOVO AML ARE ASSOCIATED WITH A VERY POOR-PROGNOSIS DESPITE INTENSIVE TREATMENT - A STUDYOF 90 PATIENTS
Authors: SCHOCH C HAFERLACH T HAASE D FONATSCH C SCHLEGELBERGER B SAUERLAND MC LOFFLER H STAIB P WORMANN B BUCHNER T HIDDEMANN W
Citation: C. Schoch et al., COMPLEX CHROMOSOME-ABERRATIONS IN PATIENTS WITH DE-NOVO AML ARE ASSOCIATED WITH A VERY POOR-PROGNOSIS DESPITE INTENSIVE TREATMENT - A STUDYOF 90 PATIENTS, Blood, 90(10), 1997, pp. 272-272
MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DIFFERENT SUBSETS OF ACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS AREASSOCIATED WITH POOR-PROGNOSIS
Authors: DREYLING MH SCHRADER C FONATSCH C SCHLEGELBERGER B HAASE D SCHOCH C LUDWIG WD BUCHNER T WORMANN B HIDDEMANN W BOHLANDER SK
Citation: Mh. Dreyling et al., MLL AND CALM ARE FUSED TO AF10 IN MORPHOLOGICALLY DIFFERENT SUBSETS OF ACUTE-LEUKEMIA WITH TRANSLOCATION T(10-11) - BOTH REARRANGEMENTS AREASSOCIATED WITH POOR-PROGNOSIS, Blood, 90(10), 1997, pp. 1417-1417
EFFECTS OF HIGH-DOSE CYTARABIN (HD-ARA-C) AS PART OF DOUBLE INDUCTIONSTRATEGY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND RESULTS OF COMBINATION WITH ALL-TRANS-RETINOIC ACID (ATRA)
Authors: LENGFELDER E REICHERT A HEHLMANN R LOFFLER H FONATSCH C SCHOCH C STAIB P SEIFARTH W SAUERLAND MC HEINECKE A WORMANN B HIDDEMANN W BUCHNER T
Citation: E. Lengfelder et al., EFFECTS OF HIGH-DOSE CYTARABIN (HD-ARA-C) AS PART OF DOUBLE INDUCTIONSTRATEGY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND RESULTS OF COMBINATION WITH ALL-TRANS-RETINOIC ACID (ATRA), Blood, 90(10), 1997, pp. 1475-1475
PROGNOSTIC RELEVANCE OF CYTOGENETIC SUBGROUPS IN 357 PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HAASE D SCHANZ J WULICH J SCHOCH C FREUND M HAFERLACH T WORMANN B STAIB P LENTINI G BARTELS H GEISSLER RG GERMING U DORGES U FONATSCH C HIDDEMANN W
Citation: D. Haase et al., PROGNOSTIC RELEVANCE OF CYTOGENETIC SUBGROUPS IN 357 PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 90(10), 1997, pp. 2232-2232
LATE EVENTS IN AML - DATA FROM LONG-TERM OBSERVATION OF PATIENTS IN 2TRIALS STARTING IN 1981 AND 1985
Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T FONATSCH C HOSSFELD D MASCHMEYER G LENGFELDER E AUL C HEYLL A LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., LATE EVENTS IN AML - DATA FROM LONG-TERM OBSERVATION OF PATIENTS IN 2TRIALS STARTING IN 1981 AND 1985, Blood, 90(10), 1997, pp. 2247-2247
THERAPEUTIC OUTCOME IN AML IS MAINLY DETERMINED BY CYTOGENETICS, LDH IN SERUM, EARLY RESPONSE AND, IN A POOR-RISK SUBGROUP, BY INTENSIFIED INDUCTION TREATMENT
Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T FONATSCH C HOSSFELD D MASCHMEYER G LENGFELDER E AUL C HEYLL A LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., THERAPEUTIC OUTCOME IN AML IS MAINLY DETERMINED BY CYTOGENETICS, LDH IN SERUM, EARLY RESPONSE AND, IN A POOR-RISK SUBGROUP, BY INTENSIFIED INDUCTION TREATMENT, Blood, 90(10), 1997, pp. 2248-2248
INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY
Authors: SPERR WR PIRIBAUER M AGIS H MITTERBAUER M GEISSLER K HAAS O FONATSCH C JAGER U SCHWARZINGER I THALHAMMER F VALENT P LECHNER K
Citation: Wr. Sperr et al., INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY, Blood, 90(10), 1997, pp. 2267-2267
Risultati: 1-25 | 26-50 | 51-75 | 76-88